Previous 10 | Next 10 |
home / stock / exas / exas articles
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Mainz Biomed NV (NASDAQ:MYNZ), a company that specializes in the early detection of cancer, recently shared encouraging topline results from a clin...
Shares of AppLovin Corporation (NASDAQ:APP) rose sharply in today's pre-market trading after the company reported better-than-expected first-q...
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. Much of the negativity in the recent session was ...
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of Exact Sciences Corporation (NASDA...
Exact Sciences Corp (NASDAQ:EXAS) shares are trading lower in Wednesday’s after-hours session on the heels of the company’s first-quart...
U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more speeches by Federal Re...
Earnings reports and a dovish stance from the Federal Reserve lifted stocks last week. Major indices reacted positively, particularly to ...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-06-26 18:30:02 ET Scotiabank analyst issues OUTPERFORM recommendation for EXAS on June 26, 2024 04:27PM ET. EXAS was trading at $44.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong Buy, ...
2024-06-26 18:00:04 ET Sung Ji Nam from Scotiabank issued a price target of $70.00 for EXAS on 2024-06-26 16:27:00. The adjusted price target was set to $70.00. At the time of the announcement, EXAS was trading at $44.16. The overall price target consensus is at $96.29 w...
2024-06-26 09:15:03 ET BTIG analyst issues BUY recommendation for EXAS on June 26, 2024 07:41AM ET. The previous analyst recommendation was Buy. EXAS was trading at $41.37 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...